ArticleCell reports2026
Pleiotrophin regulates presynaptic assembly and function through heparan sulfate-dependent binding to neurexin1.
Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Synapses are the fundamental units of neural circuits, and their dysfunction contributes to numerous neuropsychiatric disorders. Although synaptic adhesion proteins have been well studied, how extracellular cues and matrix glycans specify synaptic properties remains much less well understood. Here, we identify pleiotrophin (Ptn) as a regulator of presynaptic development. Affinity purification-based proteomics shows that Ptn associates with heparan sulfate (HS)-modified neurexin1 (HS-Nrxn1) in the brain through an HS-glycan-dependent mechanism. Glycan microarray analyses further reveal that Ptn selectively recognizes defined HS sulfation motifs. Functionally, Ptn requires both HS glycans and Nrxns to induce presynaptic assembly in cultured neurons. In vivo, Ptn deletion disrupts presynaptic protein clustering, reduces neurotransmitter release probability at CA3-CA1 synapses, and impairs contextual fear discrimination. Together, these findings establish Ptn as an extracellular organizer of presynaptic development and support a model in which Nrxn1's HS glycan provides a platform for extracellular ligand recruitment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.